These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A tale of two stents: perioperative management of patients with drug-eluting coronary stents. Head DE; Sebranek JJ; Zahed C; Coursin DB; Prielipp RC J Clin Anesth; 2007 Aug; 19(5):386-96. PubMed ID: 17869994 [TBL] [Abstract][Full Text] [Related]
3. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation. Garg P; Mauri L Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745 [TBL] [Abstract][Full Text] [Related]
5. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis? Kumbhani DJ; Bavry AA; Bhatt DL Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427 [TBL] [Abstract][Full Text] [Related]
6. Antiplatelet therapy following drug-eluting stent implantation: new clinical data and recommendations. Paradis JM; Ducrocq G; Tanguay JF Minerva Cardioangiol; 2008 Feb; 56(1):139-54. PubMed ID: 18432176 [TBL] [Abstract][Full Text] [Related]
7. Stent thrombosis after percutaneous coronary intervention for bifurcation lesions. Tan HC J Interv Cardiol; 2009 Apr; 22(2):114-6. PubMed ID: 19379468 [TBL] [Abstract][Full Text] [Related]
8. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798 [TBL] [Abstract][Full Text] [Related]
9. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384 [TBL] [Abstract][Full Text] [Related]
10. Drug-eluting stents: issues of late stent thrombosis. Lemesle G; Maluenda G; Collins SD; Waksman R Cardiol Clin; 2010 Feb; 28(1):97-105. PubMed ID: 19962052 [TBL] [Abstract][Full Text] [Related]
11. The safety of drug-eluting stents. Saia F; Marzocchi A; Branzi A Ther Adv Cardiovasc Dis; 2008 Feb; 2(1):43-52. PubMed ID: 19124407 [TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions. Han YL; Zhang J; Li Y; Wang SL; Jing QM; Yi XH; Ma YY; Luan B; Wang G; Wang B Chin Med J (Engl); 2009 Mar; 122(6):643-7. PubMed ID: 19323927 [TBL] [Abstract][Full Text] [Related]
13. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions. Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862 [TBL] [Abstract][Full Text] [Related]
14. Pathology of drug-eluting stents: implications for coronary intervention. Finn AV; Nakazawa G; Virmani R Indian Heart J; 2007; 59(2 Suppl B):B41-9. PubMed ID: 19153436 [TBL] [Abstract][Full Text] [Related]